Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-24-000012

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $64.41 ($1,288,200)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gassert Chad · SVP - CORP. DEV. & STRATEGY

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-03 Sale : show line 1 in the form 10b5-1 −20,000 $64.41 $1,288,200 213,226 I
Open-market sales · 20,000 sh · avg $64.41 · $1,288,200
Loading xslF345X05/wk-form4_1717538875.xml…